Main > ENDOCRINOLOGY > Diabetes. Treatment > Insulin. > PreMixed Insulin Inj. > Co.: USA. E (Market/Patents)

---

Co.: USA. E (Market/Patents)'s subsections
A1: Short Acting Insulin
A2: Intermediate Acting Insulin
BioSynthetic Human Insulin
Company
Human Insulin (rDNA Origin)
Patent>BioSynthesis
Patent>Crystalline ProInsulin
Patent>Formulation
Patent>Purification
Patent>Recovery>Protamine Complex
Patent>Total USA No.: 10
Patent>UpDate: 12.05.06
Patent>US Expiration: 05.11.2001
Proportions of A1 & A2:
Protamine=Hexameric Insulin
Sales>2004 = US$ 998 Million
TradeMark (USA)
Web-Site (USA)

Co.: USA. E (Market/Patents)'s products
This section has no products